Posted by Michael Wonder on 29 Dec 2022
FDA approves Polarean’s Xenoview (Xenon Xe 129 hyperpolarised) for use with MRI for the evaluation of lung ventilation
28 December 2022 - FDA approved indication includes both adolescents and adults representing a significant market opportunity
Polarean Imaging announces that the US FDA has granted approval for its drug device combination product, Xenoview.
